🇺🇸·19h agoResearch
NCT07242300: Efficacy and Safety of Recombinant Botulinum Toxin Type A (Eveotox) for Injection in the Treatment of Adult Upper Limb Spasticity .
Study type: INTERVENTIONAL. Phase: PHASE3.
Publisher
C
ClinicalTrials.gov
USA
This page provides a limited summary, publisher metadata, and related coverage to support discovery before sending readers to the original article.
Read originalAt a glance
- Publisher
- ClinicalTrials.gov
- Region
- USA
- Scope
- Research
- Published
- September 23, 2026
- Language
- EN
Publisher context, original article off-platform
This page presents the title, publisher metadata, and a limited summary excerpt to help users judge relevance first. Full-text reading stays on the publisher's original site.
Summary excerpt
Study type: INTERVENTIONAL. Phase: PHASE3.
Source route
Continue on clinicaltrials.gov
Leave the platform to read the original full article on the publisher site.
Source: ClinicalTrials.gov
Scope: Research
Related coverage
More related coverage
NIHR School for Public Health Research/5h ago
Public Mental Health Autumn Webinar: School-Based Mental Health Interventions
Quadram Institute (Bioscience)/3h ago
Quadram Institute Bioscience announces appointment of a new Chair of Trustees
McGill Faculty of Medicine News/3h ago
FMHS investigators: share your research and expertise with a broader audience
University of Minnesota/3h ago